NCT04302454
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04302454
Title Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)
Acronym ADOPT
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University Medical Center Groningen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD

Facility Status City State Zip Country Details
Radiotherapiegroep Arnhem Gelderland Netherlands Details
Radboud University Medical Center Nijmegen Gelderland Netherlands Details
Maastro Clinic Maastricht Limburg Netherlands Details
Catharina Hospital Eindhoven North Brabant Netherlands Details
Amsterdam UMC (Location VUmc) Amsterdam North Holland Netherlands Details
Radiotherapiegroep Deventer Overijssel Netherlands Details
Isala Zwolle Overijssel Netherlands Details
Radiotherapy Institute Friesland Leeuwarden Provincie Friesland Netherlands Details
Leinden University Medical Center Leiden South Holland Netherlands Details
Erasmus Medical Center Rotterdam South Holland Netherlands Details
Haga Hospital The Hague South Holland Netherlands Details
UMCG Groningen Netherlands Details
Verbeeten Institute Tilburg Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field